Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $98.15M.
ENTERPRISE VALUE (EV)
$98.15M
MaxCyte, Inc.
Market Cap
$116.76M
Enterprise Value (EV)
$98.15M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| MaxCyte, Inc. (MXCT) | $116.76M | $98.15M |
| Spruce Biosciences, Inc. (SPRB)vs › | $117.76M | $29.13M |
| Foghorn Therapeutics Inc. (FHTX)vs › | $115.67M | $90.69M |
| Tenaya Therapeutics, Inc. (TNYA)vs › | $118.59M | $44.45M |
| LENZ Therapeutics, Inc. (LENZ)vs › | $118.83M | $94.75M |
| Lucid Diagnostics Inc. (LUCD)vs › | $114.46M | $105.97M |
| Genelux Corporation (GNLX)vs › | $113.89M | $107.13M |
| Coya Therapeutics, Inc. (COYA)vs › | $113.77M | N/A |
| Cibus, Inc. (CBUS)vs › | $119.84M | $132.15M |
| Seer, Inc. (SEER)vs › | $120.41M | $116.72M |
Market Cap
$116.76M
Total Debt
$1.46M
Cash
$20.07M
Enterprise Value
$98.15M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
